
Browse
	Faculties & Departments
	Issue Date
	Author
	Title
	Communities & Collections

Sign on to:
	My DSpace authorized users

Search Results

Search:

for

Results 1-43 of 43.

Sort items by In order | Results/Page Authors/record

Item hits:

Issue Date	Title	Author(s)
2011	Molecular Remission in Follicular Lymphoma: Is the Era of Residual Disease Monitoring Over? Reply	Oers, M.H. van; Jansen, J.H.; Reijden, B.A. van der
2011	Rapid identification of IDH1 and IDH2 mutations in acute myeloid leukaemia using high resolution melting curve analysis	Noordermeer, S.M.; Tonnissen, E.; Vissers, I.; Heijden, A. van der; Locht, L.T. van de; Deutz-Terlouw, P.P.; Marijt, E.W.; Jansen, J.H.; Reijden, B.A. van der
2011	Adult metachromatic leukodystrophy treated by allo-SCT and a review of the literature	Hosson, L.D. de; Warrenburg, B.P.C. van de; Preijers, F.W.M.B.; Blijlevens, N.M.A.; Reijden, B.A. van der; Kremer, H.P.H.; Lefeber, D.J.; Allebes, W.A.; Al-Ali, H.; Niederwieser, D.W.; Schaap, N.P.M.; Schattenberg, A.V.M.B.
2011	High BRE expression predicts favorable outcome in adult acute myeloid leukemia, in particular among MLL-AF9-positive patients	Noordermeer, S.M.; Sanders, M.P.; Gilissen, C.F.; Tonnissen, E.; Heijden, A. van der; Dohner, K.; Bullinger, L.; Jansen, J.H.; Valk, P.J.; Reijden, B.A. van der
2010	The NDE1 gene is disrupted by the inv(16) in 90% of cases with CBFB-MYH11-positive acute myeloid leukemia.	Reijden, B.A. van der; Massop, M.; Simons, A.; Witte, T.J.M. de; Breuning, M.; Jansen, J.H.
2010	Gfi1 and Gfi1b: key regulators of hematopoiesis.	Meer, L.T. van der; Jansen, J.H.; Reijden, B.A. van der
2010	Somatic mutations of the histone methyltransferase gene EZH2 in myelodysplastic syndromes.	Nikoloski, G.; Langemeijer, S.M.C.; Kuiper, R.P.; Knops, R.; Massop, M.; Tonnissen, E.R.; Heijden, A. van der; Scheele, T.N.; Berghe, P. van den; Witte, T.J.M. de; Reijden, B.A. van der; Jansen, J.H.
2010	BCL-2/IgH polymerase chain reaction status at the end of induction treatment is not predictive for progression-free survival in relapsed/resistant follicular lymphoma: results of a prospective randomized EORTC 20981 phase III intergroup study.	Oers, M.H. van; Tonnissen, E.L.R.T.M.; Glabbeke, M. van; Giurgea, L.; Jansen, J.H.; Klasa, R.; Marcus, R.E.; Wolf, M.; Kimby, E.; Vranovsky, A.; Holte, H.; Hagenbeek, A.; Reijden, B.A. van der
2010	A variant allele of Growth Factor Independence 1 (GFI1) is associated with acute myeloid leukemia.	Khandanpour, C.; Thiede, C.; Valk, P.J.; Sharif-Askari, E.; Nuckel, H.; Lohmann, D.; Horsthemke, B.; Siffert, W.; Neubauer, A.; Grzeschik, K.H.; Bloomfield, C.D.; Marcucci, G.; Maharry, K.; Slovak, M.L.; Reijden, B.A. van der; Jansen, J.H.; Schackert, H.K.; Afshar, K.; Schnittger, S.; Peeters, J.K.; Kroschinsky, F.; Ehninger, G.; Lowenberg, B.; Duhrsen, U.; Moroy, T.
2010	MicroRNA hsa-miR-135b regulates mineralization in osteogenic differentiation of human unrestricted somatic stem cells.	Oziemlak, A.M.; Raymakers, R.A.P.; Bergevoet, S.M.; Gilissen, C.F.H.A.; Jansen, B.J.H.; Adema, G.J.; Kogler, G.; Sage, C. le; Agami, R.; Reijden, B.A. van der; Jansen, J.H.
2010	Hematopoietic stem cells exhibit a specific ABC transporter gene expression profile clearly distinct from other stem cells	Tang, L.; Bergevoet, S.M.; Gilissen, C.F.H.A.; Witte, T.J.M. de; Jansen, J.H.; Reijden, B.A. van der; Raymakers, R.A.P.
2009	Exclusion of ABCB8 and ABCB10 as cancer candidate genes in acute myeloid leukemia.	Tang, L.; Bergevoet, S.M.; Franssen, L.E.; Witte, T.J.M. de; Jansen, J.H.; Raymakers, R.A.P.; Reijden, B.A. van der
2009	Growth factor independent 1b (Gfi1b) and a new splice variant of Gfi1b are highly expressed in patients with acute and chronic leukemia.	Vassen, L.; Khandanpour, C.; Ebeling, P.; Reijden, B.A. van der; Jansen, J.H.; Mahlmann, S.; Duhrsen, U.; Moroy, T.
2009	The ubiquitin ligase Triad1 inhibits myelopoiesis through UbcH7 and Ubc13 interacting domains.	Marteijn, J.A.F.; Meer, L.T. van der; Smit, J.J.; Noordermeer, S.M.; Wissink, W.; Jansen, P.; Swarts, H.G.P.; Hibbert, R.G.; Witte, T.J.M. de; Sixma, T.K.; Jansen, J.H.; Reijden, B.A. van der
2009	Chemokine induction by all-trans retinoic acid and arsenic trioxide in acute promyelocytic leukemia: triggering the differentiation syndrome.	Luesink, M.; Pennings, J.L.; Wissink, W.M.; Linssen, P.C.M.; Muus, P.; Pfundt, R.P.; Witte, T.J.M. de; Reijden, B.A. van der; Jansen, J.H.
2009	Acquired mutations in TET2 are common in myelodysplastic syndromes.	Langemeijer, S.M.C.; Kuiper, R.P.; Berends, M.; Knops, G.H.J.N.; Aslanyan, M.G.; Massop, M.; Linders, E.H.P.; Hoogen, P.C.M. van; Geurts van Kessel, A.H.M.; Raymakers, R.A.P.; Kamping, E.J.; Verhoef, G.E.; Verburgh, E.; Hagemeijer, A.; Berghe, P. van den; Witte, T.J.M. de; Reijden, B.A. van der; Jansen, J.H.
2009	Real-time quantitative polymerase chain reaction detection of minimal residual disease by standardized WT1 assay to enhance risk stratification in acute myeloid leukemia: a European LeukemiaNet study.	Cilloni, D.; Renneville, A.; Hermitte, F.; Hills, R.K.; Daly, S.; Jovanovic, J.V.; Gottardi, E.; Fava, M.; Schnittger, S.; Weiss, T.; Izzo, B.; Nomdedeu, J.; Heijden, A. van der; Reijden, B.A. van der; Jansen, J.H.; Velden, V.H. van der; Ommen, H.; Preudhomme, C.; Saglio, G.; Grimwade, D.
2009	NOD2 polymorphisms predict severe acute graft-versus-host and treatment-related mortality in T-cell-depleted haematopoietic stem cell transplantation.	Velden, W.J.F.M. van der; Blijlevens, N.M.A.; Maas, F.M.H.M.; Schaap, N.P.M.; Jansen, J.H.; Reijden, B.A. van der; Feuth, A.B.; Dolstra, H.; Donnelly, J.P.
2008	C/EBPalpha, do not forget your TIP60.	So, C.W.; Reijden, B.A. van der
2008	The transcription factor nuclear factor Y regulates the proliferation of myeloid progenitor cells.	Wageningen, S. van; Nikoloski, G.; Vierwinden, G.; Knops, R.; Reijden, B.A. van der; Jansen, J.H.
2008	Gene transactivation without direct DNA binding defines a novel gain-of-function for PML-RARalpha	Wageningen, S. van; Breems-de Ridder, M.C.; Nigten, J.; Nikoloski, G.; Erpelinck-Verschueren, C.A.; Lowenberg, B.; Witte, T.J.M. de; Tenen, D.G.; Reijden, B.A. van der; Jansen, J.H.
2007	Therapy-related, donor-derived AML responding to a second allogeneic BMT.	Jacobs, J.F.M.; Brons, P.P.T.; Simons, A.; Reijden, B.A. van der; Hoogerbrugge, P.M.
2007	Sequence polymorphism systems for quantitative real-time polymerase chain reaction to characterize hematopoietic chimerism-high informativity and sensitivity as well as excellent reproducibility and precision of measurement.	Willasch, A.; Schneider, G.; Reincke, B.S.; Shayegi, B.; Kreyenberg, H.; Kuci, S.; Weber, G.; Reijden, B.A. van der; Niethammer, D.; Klingebiel, T.; Bader, P.
2007	The ubiquitine-proteasome route in normal and malignant hematopoiesis. Dutch.	Marteijn, J.A.F.; Jansen, J.H.; Reijden, B.A. van der
2007	Diminished proteasomal degradation results in accumulation of Gfi1 protein in monocytes	Marteijn, J.A.F.; Meer, L.T. van der; Emst, L. van; Jansen, P.; Witte, T.J.M. de; Jansen, J.H.; Reijden, B.A. van der
2007	Gfi1 ubiquitination and proteasomal degradation is inhibited by the ubiquitin ligase Triad1.	Marteijn, J.A.F.; Meer, L.T. van der; Emst, L. van; Reijmersdal, S.V. van; Wissink, W.; Witte, T.J.M. de; Jansen, J.H.; Reijden, B.A. van der
2006	Isolation of RNA and DNA from leukocytes and cDNA synthesis.	Jansen, J.H.; Reijden, B.A. van der
2006	Diagnosis and monitoring of CBFB-MYH11-positive acute myeloid leukemia by qualitative and quantitative RT-PCR.	Reijden, B.A. van der; Jansen, J.H.
2006	Identification of truncated RUNX1 and RUNX1-PRDM16 fusion transcripts in a case of t(1;21)(p36;q22)-positive therapy-related AML.	Stevens-Kroef, M.J.P.L.; Schoenmakers, E.F.P.M.; Kraaij, M.G.J. van; Huys, E.; Vermeulen, S.; Reijden, B.A. van der; Geurts van Kessel, A.H.M.
2006	Preferential expression of a high number of ATP binding cassette transporters in both normal and leukemic CD34+CD38- cells.	Grouw, P.L.M. de; Raaijmakers, M.G.P.; Boezeman, J.B.M.; Reijden, B.A. van der; Locht, L.T. van de; Witte, T.J.M. de; Jansen, J.H.; Raymakers, R.A.P.
2006	Ubiquitylation in normal and malignant hematopoiesis: novel therapeutic targets.	Marteijn, J.A.F.; Jansen, J.H.; Reijden, B.A. van der
2006	[A man with oral ulcers caused by hypereosinophilic syndrome and a good response to the tyrosine-kinase inhibitor imatinib]	Verstappen, M.C.; Mattijssen, V.; Reijden, B.A. van der; Heijden, A.G. van der; Wahab, P.J.; Vries, R.A. de
2006	Isolation of FRET-positive cells using single 408-nm laser flow cytometry.	Wageningen, S. van; Pennings, A.H.M.; Reijden, B.A. van der; Boezeman, J.B.M.; Lange, F. de; Jansen, J.H.
2006	ABCB1 modulation does not circumvent drug extrusion from primitive leukemic progenitor cells and may preferentially target residual normal cells in acute myelogenous leukemia.	Raaijmakers, M.G.P.; Grouw, P.L.M. de; Reijden, B.A. van der; Witte, T.J.M. de; Jansen, J.H.; Raymakers, R.A.P.
2005	Retinoic acid-dependent gene transactivation by PML-RAR without direct DNA-binding.	Wageningen, S. van; Nigten, J.; Breems-de Ridder, M.C.; Nikoloski, G.; Erpelinck-Verschueren, C.A.; Lowenberg, B.; Witte, T.J.M. de; Reijden, B.A. van der; Jansen, J.H.
2005	Impaired breast cancer resistance protein mediated drug transport in plasma cells in multiple myeloma.	Raaijmakers, M.G.P.; Grouw, P.L.M. de; Heuver, L.H.; Reijden, B.A. van der; Jansen, J.H.; Scheffer, G.; Scheper, R.J.; Witte, T.J.M. de; Raymakers, R.A.P.
2005	Transcriptional repression of the Neurofibromatosis-1 tumor suppressor by the t(8;21) fusion protein.	Yang, G.; Khalaf, W.; Locht, L.; Jansen, J.H.; Gao, M.; Thompson, M.A.; Reijden, B.A. van der; Gutmann, D.H.; Delwel, R.; Clapp, D.W.; Hiebert, S.W.
2005	Expression of C-IAP1, C-IAP2 and SURVIVIN discriminates different types of lymphoid malignancies.	Graaf, A.O. de; Krieken, J.H.J.M. van; Tonnissen, E.L.R.; Wissink, W.J.M.; Locht, L.; Overes, I.M.; Dolstra, H.; Witte, T.J.M. de; Reijden, B.A. van der; Jansen, J.H.
2005	ID1 and ID2 are retinoic acid responsive genes and induce a G0/G1 accumulation in acute promyelocytic leukemia cells.	Nigten, J.; Ridder, M.C. de; Erpelinck-Verschueren, C.A.; Nikoloski, G.; Reijden, B.A. van der; Wageningen, S. van; Hennik, P.B. van; Witte, T.J.M. de; Lowenberg, B.; Jansen, J.H.
2005	The E3 ubiquitin-protein ligase Triad1 inhibits clonogenic growth of primary myeloid progenitor cells.	Marteijn, J.A.F.; Emst, J.E. van; Erpelinck-Verschueren, C.A.; Nikoloski, G.; Menke, A.; Witte, T.J.M. de; Lowenberg, B.; Jansen, J.H.; Reijden, B.A. van der
2005	Breast cancer resistance protein in drug resistance of primitive CD34+38- cells in acute myeloid leukemia.	Raaijmakers, M.G.P.; Grouw, P.L.M. de; Heuver, L.H.; Reijden, B.A. van der; Jansen, J.H.; Scheper, R.J.; Scheffer, G.L.; Witte, T.J.M. de; Raymakers, R.A.P.
2004	Epigenetic regulation of tumor suppressors in t(8:21)-containing AML.	Yang, G.; Khalaf, W.; Locht, L.A. van de; Jansen, J.H.; Reijden, B.A. van der; Muller-Tidow, C.; Delwel, H.R.; Serve, H.; Clapp, D.W.; Hiebert, S.W.
2004	Bcl-2 prevents loss of mitochondria in CCCP-induced apoptosis.	Graaf, A.O. de; Heuvel, L.P.W.J. van den; Dijkman, H.B.P.M.; Abreu, R.A. de; Birkenkamp, K.U.; Witte, T.J.M. de; Reijden, B.A. van der; Smeitink, J.A.M.; Jansen, J.H.